APO-MIDODRINE DIN 02278677
Health Canada record
| Active ingredient(s) | MIDODRINE HYDROCHLORIDE 2.5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C01CA17 MIDODRINE |
| Original market date | 13-Jun-2006 |
| Current status date | 10-Dec-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MIDODRINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02278685 | APO-MIDODRINE | APOTEX INC | Tablet | MIDODRINE HYDROCHLORIDE 5 MG | Marketed |
| 02517701 | JAMP MIDODRINE | JAMP PHARMA CORPORATION | Tablet | MIDODRINE HYDROCHLORIDE 2.5 MG | Marketed |
| 02517728 | JAMP MIDODRINE | JAMP PHARMA CORPORATION | Tablet | MIDODRINE HYDROCHLORIDE 5 MG | Marketed |
| 02547120 | M-MIDODRINE | MANTRA PHARMA INC | Tablet | MIDODRINE HYDROCHLORIDE 5 MG | Marketed |
| 02547112 | M-MIDODRINE | MANTRA PHARMA INC | Tablet | MIDODRINE HYDROCHLORIDE 2.5 MG | Marketed |
| 02473984 | MAR-MIDODRINE | MARCAN PHARMACEUTICALS INC | Tablet | MIDODRINE HYDROCHLORIDE 2.5 MG | Marketed |
| 02473992 | MAR-MIDODRINE | MARCAN PHARMACEUTICALS INC | Tablet | MIDODRINE HYDROCHLORIDE 5 MG | Marketed |
| 02533200 | MIDODRINE | SANIS HEALTH INC | Tablet | MIDODRINE HYDROCHLORIDE 2.5 MG | Marketed |
| 02533219 | MIDODRINE | SANIS HEALTH INC | Tablet | MIDODRINE HYDROCHLORIDE 5 MG | Marketed |
| 01934406 | AMATINE | SHIRE PHARMA CANADA ULC | Tablet | MIDODRINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 01934392 | AMATINE | SHIRE PHARMA CANADA ULC | Tablet | MIDODRINE HYDROCHLORIDE 2.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21451 | 2018-10-19 | Abbreviated New Drug Submission (ANDS) | Labelling Assessment and Administrative: Change in product Ownership |
| 11429 | 2010-05-27 | Abbreviated New Drug Submission (ANDS) | Manufacturer and product name change |
| 7827 | 2006-03-13 | Abbreviated New Drug Submission (ANDS) |
International API supply for MIDODRINE HYDROCHLORIDE
14 active FDA Drug Master Files.
Request a quote for APO-MIDODRINE